SCHEMBL7975136

SCHEMBL7975136

Cc1ccc(Cn2cnc3nc(CCN)[nH]c(=O)c32)cc1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.45
ALDH1A1 P00352 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
KMT2A Q03164 1/20 0.44
BRD4 O60885 3/20 0.40
HCAR2 Q8TDS4 1/20 0.38
LMNA P02545 2/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
HTT P42858 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 2/20 0.37
DCTPP1 Q9H773 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989373 0.89 HPGD (0.46) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7974302 0.88 SMN1; SMN2 (0.45) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7985634 0.88 SMN1; SMN2 (0.57) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7985636 0.88 ABCC8 (0.47) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
Hydrochloric Acid SCHEMBL7987615 0.87 SMN1; SMN2 (0.56) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7987432 0.87 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7992185 0.87 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7988041 0.84 SMN1; SMN2 (0.47) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
Hydrochloric Acid SCHEMBL7988136 0.83 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7988672 0.82 SMN1; SMN2 (0.47) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed